{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T16:21:27Z","timestamp":1778775687477,"version":"3.51.4"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>OBJECTIVES:<\/jats:title>\n            <jats:p>Guidelines recommend hydrocortisone as an adjunctive treatment in septic shock, but the optimal dosing regimen is unknown. A national shortage of hydrocortisone in 2023 prompted a change in institutional practice for hydrocortisone administration from 50\u2009mg every 6 hours to 100\u2009mg every 12 hours in an effort to reduce waste and conserve vials, creating an opportunity to evaluate the comparative effectiveness of these two regimens. The primary efficacy outcome was time to shock resolution, and secondary outcomes evaluated in this study were mortality, renal replacement therapy (RRT), medication costs, and maximum vasopressor dose attained.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>DESIGN:<\/jats:title>\n            <jats:p>Single-center, retrospective cohort study.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>SETTING:<\/jats:title>\n            <jats:p>ICUs in a quaternary academic medical center.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>PATIENTS:<\/jats:title>\n            <jats:p>Adult patients admitted to an ICU with septic shock, defined by mean arterial pressure less than 65\u2009mm Hg despite adequate fluid resuscitation and need for vasopressor infusion, who were treated with hydrocortisone for shock between October 24, 2022, and October 12, 2023.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>INTERVENTIONS:<\/jats:title>\n            <jats:p>Treatment with hydrocortisone 50\u2009mg every 6 hours or 100\u2009mg every 12 hours.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>MEASUREMENTS AND MAIN RESULTS:<\/jats:title>\n            <jats:p>One hundred thirty-eight patients were included in this retrospective chart review from October 24, 2022, to October 12, 2023. Data for 61 patients in the 50\u2009mg every 6 hours group and 77 patients in the 100\u2009mg every 12 hours group were collected and analyzed. In adjusted competing risk models, hydrocortisone regimen was not associated with differences in time to shock resolution (sub-hazard ratio [sub-HR] 0.95 [95% CI, 0.59\u20131.54]), ICU mortality (sub-HR 1.59; 95% CI, 0.89\u20132.84), in-hospital mortality (1.35; 95% CI, 0.81\u20132.26), or time to RRT (sub-HR 1.01; 95% CI, 0.45\u20132.31). In addition, the hydrocortisone dose regimen was not associated with differences in maximum vasopressor dose attained (mean difference in norepinephrine equivalent, 0.16 \u00b5g\/kg\/min; 95% CI, \u20130.26 to 0.58 \u00b5g\/kg\/min). The less frequent dosing resulted in cost savings of $446.10 (95% CI, 253.95\u2013638.25) per patient treated with the more intensive but less frequent hydrocortisone dosing regimen.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSIONS:<\/jats:title>\n            <jats:p>A less frequent hydrocortisone dosing regimen was not associated with differences in time to shock resolution. Studies of the comparative effectiveness of different corticosteroid dosing regimens for septic shock are needed.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/cce.0000000000001316","type":"journal-article","created":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T20:00:09Z","timestamp":1757966409000},"page":"e1316","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Comparative Effectiveness of Less vs. More Frequent Hydrocortisone Dosing in Septic Shock"],"prefix":"10.1097","volume":"7","author":[{"given":"Alan","family":"Hao","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Baylor St. Luke\u2019s Medical Center, Houston, TX."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianshi David","family":"Wu","sequence":"additional","affiliation":[{"name":"Section of Pulmonary, Critical Care, and Sleep Medicine, Baylor College of Medicine, Houston, TX."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keegan","family":"Collins","sequence":"additional","affiliation":[{"name":"Section of Pulmonary, Critical Care, and Sleep Medicine, Baylor College of Medicine, Houston, TX."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle","family":"Guffey","sequence":"additional","affiliation":[{"name":"Institute for Clinical and Translational Research, Baylor College of Medicine, Houston, TX."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Kessinger","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Baylor St. Luke\u2019s Medical Center, Houston, TX."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meghna","family":"Vallabh","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Baylor St. Luke\u2019s Medical Center, Houston, TX."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Omranian","sequence":"additional","affiliation":[{"name":"Section of Pulmonary, Critical Care, and Sleep Medicine, Baylor College of Medicine, Houston, TX."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,9,15]]},"reference":[{"key":"R1-20250915","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1001\/jama.288.7.862","article-title":"Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock.","volume":"288","author":"Annane","year":"2002","journal-title":"JAMA"},{"key":"R2-20250915","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMoa1705716","article-title":"Hydrocortisone plus fludrocortisone for adults with septic shock.","volume":"378","author":"Annane","year":"2018","journal-title":"N Engl J Med"},{"key":"R3-20250915","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa071366","article-title":"Hydrocortisone therapy for patients with septic shock.","volume":"358","author":"Sprung","year":"2008","journal-title":"N Engl J Med"},{"key":"R4-20250915","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1056\/NEJMoa1705835","article-title":"Adjunctive glucocorticoid therapy in patients with septic shock.","volume":"378","author":"Venkatesh","year":"2018","journal-title":"N Engl J Med"},{"key":"R5-20250915","doi-asserted-by":"crossref","first-page":"e219","DOI":"10.1097\/CCM.0000000000006172","article-title":"2024 focused update: Guidelines on use of corticosteroids in sepsis, acute respiratory distress syndrome, and community-acquired pneumonia.","volume":"52","author":"Chaudhuri","year":"2024","journal-title":"Crit Care Med"},{"key":"R7-20250915","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"R8-20250915","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.resuscitation.2012.12.016","article-title":"The ability of the National Early Warning Score (NEWS) to discriminate patients at risk of early cardiac arrest, unanticipated intensive care unit admission, and death.","volume":"84","author":"Smith","year":"2013","journal-title":"Resuscitation"},{"key":"R9-20250915","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/00003246-198510000-00009","article-title":"APACHE II: A severity of disease classification system.","volume":"13","author":"Knaus","year":"1985","journal-title":"Crit Care Med"},{"key":"R10-20250915","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13054-023-04322-y","article-title":"An updated \u201cnorepinephrine equivalent\u201d score in intensive care as a marker of shock severity.","volume":"27","author":"Kotani","year":"2023","journal-title":"Crit Care"},{"key":"R12-20250915","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2165\/00003088-200544010-00003","article-title":"Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids.","volume":"44","author":"Czock","year":"2005","journal-title":"Clin Pharmacokinet"},{"key":"R14-20250915","first-page":"e0940","article-title":"Alternatives to hydrocortisone for hemodynamic support in septic shock management due to medication shortage.","volume":"5","author":"Aldhaeefi","year":"2023","journal-title":"Crit Care Explor"},{"key":"R15-20250915","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1186\/cc1515","article-title":"Clinical review: Splanchnic ischaemia.","volume":"6","author":"Jakob","year":"2002","journal-title":"Crit Care"},{"key":"R16-20250915","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s13054-017-1659-4","article-title":"Corticosteroids in septic shock: A systematic review and network meta-analysis.","volume":"21","author":"Gibbison","year":"2017","journal-title":"Crit Care"}],"container-title":["Critical Care Explorations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CCE.0000000000001316","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T20:00:11Z","timestamp":1757966411000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CCE.0000000000001316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":13,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/cce.0000000000001316","relation":{},"ISSN":["2639-8028"],"issn-type":[{"value":"2639-8028","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9]]}}}